Palatin Technologies Inc. (PTN)

[BesaoT35]

PTN got a patent for treatment of diabetes and obesity, divestment of Vyleesi from AMAG is due any day, solid financials and no buyer interest whatsoever. There must be some sort of negativity that is not being discussed enough. It must be a management that takes away the money that shareholders deserve for company successes and manages to move that money into high salaries and bonuses and other perks for themselves.

The price per share is too low except if there was a reason that relates to a shareholder loss of faith in management. Otherwise the stock would be higher.

I also think that more PR activity and shareholder letters would help support the stock price. Investor relations could be improved in my opinion.